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Mutations and deregulation of adenomatous polypo-
sis coli (APC) and -catenin are implicated in specific
cancers of the pancreas, but the role of Wnt pathway
in normal pancreas development and homeostasis is
unknown [1–4]. This article reports a comprehensive
investigation of the activity and the role of the Wnt
pathway in pancreas organogenesis. We have used
two reporter lines to monitor canonical Wnt pathway
activity during development and after birth and de-
monstrate activity in endocrine cells and in the mes-
enchyme. We have specifically deleted the -catenin
gene in the epithelium of the pancreas and duodenum
by using Pdx1-Cre mice. In agreement with Wnt path-
way activity in pancreatic endocrine cells, we find a
reduction in endocrine islet numbers. Our study re-
veals that -catenin deletion also affects cells in
which Wnt pathway activity is not detected. Indeed,
-catenin mutant cells have a competitive disadvan-
tage during development that also affects the exo-
crine compartment. Moreover, the conditional knock-
out (KO) mice develop acute edematous pancreatitis
perinatally due to the disruption of the epithelial
structure of acini. These effects are likely to be due
to the function of -catenin at the membrane. Mice
later recover from pancreatitis and regenerate normal
pancreas and duodenal villi from the wild-type (wt)
cells that escape -catenin deletion.
Results
The Wnt/-Catenin Pathway Is Active during
Pancreas Development in Endocrine Cells
Several Wnt pathway components have been detected
by RT-PCR and in situ hybridization at different stages
in both the developing mouse pancreas and in human
adult pancreas [5–7]. In order to investigate the activity
of the Wnt/β-catenin pathway during pancreas organo-
genesis, we have used a mouse reporter strain in which
lacZ was inserted into the locus of the Wnt target gene
conductin/axin2 [8]. Conductin is transcriptionally acti-
vated by the canonical Wnt pathway through TCF bind-
ing sites in its promoter and appears to participate in a
negative feedback loop [8, 9]. At 12.5 days post coitus*Correspondence: anne.grapin@isrec.ch(dpc) (data not shown) and 14.5 dpc (Figures 1A–1E),
lacZ staining is found in clusters of epithelial cells (Fig-
ure 1E) that coexpress glucagon or insulin (Figures 1B–
1D). Most endocrine cells are lacZ+. At this stage, stain-
ing is also detected in the lung epithelium, confirming
the canonical Wnt pathway activity already demon-
strated by using the TOP-gal or BAT-gal reporter mice
(data not shown) [10, 11]. At 15.5 dpc, Wnt activity is
observed in the duodenum at the base of the nascent
villi, where the crypts will later form, a known site of
Wnt pathway activity that is not detected in the BAT-
gal mice (Figures 1M and 1N). Activity is maintained in
islets of newborn mice (Figures 1K and 1L) but is lost
in the pancreas of 6-week-old mice (data not shown).
As reporter strains for the canonical Wnt pathway might
monitor only a subset of cells in which this pathway is
active, we have used the BAT-gal reporter mice to de-
tect possible additional sites of activity in the pancreas
(Figures 1F–1J) [11]. This reporter reveals high activity
in numerous mesenchymal cells (Figure 1F, black ar-
rowheads) and lower levels in most epithelial (Figure 1J,
white arrowhead) endocrine cells expressing glucagon
(Figures 1G–1I). Wnt pathway activity in the pancreas is
not detected in the acinar and ductal compartments at
any stage in both strains (Figure 1O).
Competitive Disadvantage of -Catenin-Negative
Cells in a Mosaic Pancreatic Environment
β-catenin plays a central role in the canonical Wnt sig-
naling pathway [12, 13]. β-catenin-deficient mice die
around 6–7 dpc [14]. This early embryonic lethality has
precluded analyses of β-catenin functions during later
development and organogenesis. In order to delete
β-catenin in the pancreas, we have crossed Pdx1-Cre
transgenic animals [15] with mice heterozygous for a
b-catenin null allele (b-cat+/lacZ). Heterozygous b-catenin
KO animals are viable, fertile, and show no develop-
mental abnormalities [14]. We have crossed animals that
carried the hemizygous transgene and one b-catenin null
allele with mice homozygous for the floxed b-catenin
allele [16]. These floxed mice have previously been
used to successfully inactivate β-catenin in vivo [16–19].
This combination of alleles optimizes deletion effi-
ciency, as only one floxed allele needs to be recom-
bined to delete b-catenin. Lineage analyses using the
cre-lox system have demonstrated that Pdx1-express-
ing cells will give rise to all cells of the pancreas (ducts,
acini, and islets) [15, 20, 21]. Pdx1 is expressed as early
as 8.5 dpc in the pancreas anlage and remains ex-
pressed in all pancreatic epithelial cells as the dorsal
and ventral buds evaginate in the mesenchyme. As
cells differentiate from progenitors, Pdx1 expression
ceases in α (glucagon), δ (somatostatin), PP (pancreatic
polypeptide), and ductal cells and is strongly downreg-
ulated in acinar cells. It is maintained throughout adult-
hood in insulin-expressing β cells [22, 23]. To confirm
the efficiency of the Pdx1-Cre transgene, we have used
a recombinase inducible YFP reporter under the control
of the ROSA26 locus (R26R-YFP) [24]. This reporter
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1678Figure 1. β-Galactosidase Staining in Conductin-lacZ and BAT-Gal Embryos Shows Activity of the Wnt/β-Catenin Pathway during Pancreas
Development.
Conductin-lacZ mice (A–E and K–M) and BAT-gal mice (F–J, N, and O).
(A) Pancreas section at 14.5 dpc showing labeled endocrine cell clusters (white arrow) and unlabeled ducts (black arrow).
(B–D) Pictures showing on the same section colocalization of lacZ blue staining (B) and glucagon (C), overlay in (D).
(E) Overlay of an adjacent section, costained for lacZ and E-cadherin, highlighting epithelium.
(F) Section of pancreas from BAT-gal embryos at 14.5 dpc showing strong positive cells in the mesenchyme (black arrowheads) and lighter
cells in the epithelium (white arrowhead).
(G and H) Pictures of the same section for lacZ nuclear blue staining (G) and glucagon (H), overlay in (I).
(J) Overlay of an adjacent section, costained for lacZ and E-cadherin, highlighting epithelium. The white arrowhead points to lacZ+ cells in
the epithelium.
(K and L) Pancreas from newborn showing colocalization on the same section of lacZ staining and insulin. The blue precipitate obtained after
staining on sections (K) is more granular than after whole-mount staining (A and M).
(M and N) Duodenum section showing blue staining at the base of villi in conductin-lacZ embryo at 15.5 dpc, but not in BAT-gal duodenum (N).
(O) Section of 14.5 dpc BAT-gal pancreas costained for lacZ and amylase. Scale bars, 100 m.was bred into the control and conditional KO back-
grounds described above. 29% of the epithelial cells
(PDX1+) express YFP at 12.5 dpc (data not shown), and
at 14.5 dpc, this proportion is increased to 57% in KO
mice (Pdx-Cre; R26R-YFP; b-cat flox/lacZ, Figure 2B), but
only 28% of these cells are negative for membranous
β-catenin protein (Figures S1A and S1B available in the
Supplemental Data with this article online). Lower re-
combination at the β-catenin locus, the long half-life of
membranous β-catenin protein, and/or counter selec-
tion against β-catenin KO cells may account for this
observation. Interestingly, at 12.5 dpc 37% (data not
shown) and at 14.5 dpc 80% of epithelial cells are re-
combined in controls (Pdx-Cre; R26R-YFP; b-cat flox/wt)
as quantified by YFP expression (Figure 2A). The pro-
portion of recombined cells in KO is therefore 22%
lower than in controls at 12.5 dpc, and this percentage
increases to 30% at 14.5 dpc. This observation sug-
gests that in a mosaic situation, cells that have lost
β-catenin are progressively out competed by nonre-




















letitive disadvantage may also explain why β-catenin-
egative cells do not accumulate over time (see below
n newborn and adult). The overall proliferation (as mea-
ured by BrdU incorporation) is unchanged in the 14.5
pc pancreas of KO animals. In order to reach statisti-
al significance, the proliferation index of β-catenin-
egative cells was quantified in homozygous Pdx-Cre
nimals where deletion efficiency is increased: β-cat-
nin-negative cells proliferated 50% less than β-catenin-
ositive cells (33.2% ± 1.6% SEM versus 67.8% ± 6.8%
EM BrdU+). Apoptosis (as measured by immuno-
taining for cleaved caspase 3) is extremely low in wt
nd is unaffected in the pancreas of mutant embryos
data not shown).
ndocrine Cells Reduction during Development
t 12.5 and 14.5 dpc, both ventral and dorsal buds of
he mutants exhibit a normal size and comparable Pdx1
xpression (Figure S2), but the pancreatic epithelium is
isorganized, and KO cells exiting the duodenal epithe-
ium are found in the mesenchyme (Figures S1C and
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1679Figure 2. β-Catenin Mutant Cells Show a Competitive Disadvantage
Fluorescence pictures show YFP expression (green) from recombina-
tion reporter and DAPI (blue) highlighting nuclei in (A)–(D). Pancreas
sections at 14.5 dpc of control (Pdx-Cre+; R26R-YFP; b-catflox/wt) (A)
reveal more YFP-positive cells than conditional KOs (Pdx-Cre+;
R26R-YFP; b-catflox/lacZ) (B). The proportion of recombined epithe-
lial cells was further quantified by dividing the number of YFP+ cells
by the number of PDX1+ cells. Pancreas sections from newborn
control (Pdx-Cre+; R26R-YFP; b-catflox/wt) (C and E) and conditional
KOs (Pdx-Cre+; R26R-YFP; b-catflox/lacZ) (D and F) demonstrate re-
combination in most of pancreatic epithelial cells (C and D).
Immunostaining for β-catenin on the same sections in control (E)
and conditional KOs (F). (G) shows a Western blot of newborn pan-
creas protein lysates showing comparable amounts of β-catenin
protein in both control and conditional KOs. Control lanes 1–3, Pdx-
Cre−; b-catflox/wt; control lane 4, Pdx-Cre+; b-catflox/wt; and KO lanes
5–7, Pdx-Cre+; b-cat flox/lacZ. The controls are protein lysates from
primary keratinocytes of wt (pos. ctr) and Cytokeratin14-Cre;
b-cat flox/lacZ mice (neg.ctr).
Scale bar in (A) and (B), 50 m, and scale bar in (C)–(F), 100 m.S1D). As the Wnt pathway is specifically active in en-
docrine cells, we have investigated in greater detail en-
docrine-cell differentiation. The number of endocrine
cells is similar in both conditional KO and control tis-
sues at 12.5 dpc. However at 14.5 dpc, the total num-
bers of glucagon- and insulin-expressing cells are
decreased to 56% and 46% of control values in condi-
tional littermate KO embryos (data not shown). The ra-
tio of glucagon- and insulin-producing cells remains
constant in mutant pancreas. In newborns, the number
of big and small islets is decreased in conditional KO
to 60% of control values (Figure 3). The total surface ofFigure 3. Pancreas of Newborn Conditional KO Mice Have De-
creased Islets Numbers
Quantitative analysis of endocrine islets in newborns using
immunostaining for insulin. Quantification was performed on every
tenth section, covering the entire pancreas. Small islets contain
three to ten cells and big islets more than ten cells. Bars indicate
mean ± SEM (n = 3).islets is also decreased to 60% of control values (data
not shown).
Acute Edematous Pancreatitis in 18.5 dpc and
Newborn Mutants
In the pancreas of newborn mice, more than 90% of
epithelial cells have recombined the R26R locus in both
controls and conditional KOs (Figures 2C and 2D).
However, a Western blot on protein lysates shows no
significant decrease of β-catenin protein in conditional
KO (Figure 2G). These results show that between 14.5
dpc and birth, the proportion of cells that have undergone
recombination at the R26R locus has increased (from
57% to 90%) in pancreatic epithelial cells but that most
of these cells have not deleted the b-catenin locus. Nev-
ertheless, a strong reduction of the β-catenin protein is
observed at the membrane in the exocrine compartment
of newborn conditional KOs (Figures 2E and 2F). This
suggests that the protein is not absent but displaced from
the membrane in wt cells.
The gross morphology of the pancreas from mutant
mice appears normal at 18.5 dpc and in newborns (Fig-
ures 4A and 4B), suggesting that wt cells largely com-
pensate for the loss of β-catenin KO cells. However, the
conditional KOs display inter- and intra-lobular edema
(Figures 4C and 4D). Large regions of the pancreas ex-
hibit disorganized acini, with round cells exiting the epi-
thelium (Figure 4L). Goldner trichrome staining, which
reveals collagen in green, shows that the interstitial
space between acini does not contain collagen depos-
its but has accumulated fluid (data not shown). In addi-
tion, electron microscopy reveals numerous vacuoles
in 50% of acinar cells of KO tissue (Figures 4H and 4L).
These histological observations are typical for mild
forms of acute edematous pancreatitis seen in humans
or in mouse models after induction with cerulein, which
triggers exocrine enzyme release [25]. In this experi-
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1680Figure 4. Newborn Conditional KOs Show Acute Edematous Pancreatitis and Reduced Duodenal Villi
Gross morphology of control (Pdx-Cre+; b-catflox/wt) (A) and conditional KO (Pdx-Cre+; b-catflox/lacZ) (B) pancreas at birth (white arrow, pan-
creas; white arrowhead, duodenum). Sections through the pancreas of control (C) and conditional KOs (D) stained with H&E show fluid
infiltration in the pancreas. H&E staining of the duodenum of control (E) and conditional KOs (F) showing duodenum villi destruction and
shortening in conditional KOs (F), black arrows point to villi. Scale bar in (C)–(F), 100 m. Electron microscopy pictures of a control acinus
(G) or conditional KO acini (H and L). Vacuolated cells in conditional KOs are not present in control. Scale bar in (G), (H), and (L), 10 m.
Higher magnification of the black squares in (G) and (H) are shown in (I) and (J), respectively. We could observe adherens junctions (black
arrowheads) and desmosomes (black arrows). Scale bar in (I) and (J), 1 m. Numbers of Ki67-positive cells in sections of control and
conditional KOs (counted on five sections for each) showing a decrease in proliferation of conditional KOs. Bars indicate mean ± SD (K).
E-cadherin and plakoglobin are present in the conditional KOs ([N] and [P], respectively) in a pattern comparable to control ([M] and [O],
respectively). Scale bar in (M) and (N), 20 m and scale bar in (O) and (P), 50 m.mental model, dissociation of β-catenin from adherens
junctions is also reported [26]. To investigate whether
cell adhesion was generally disrupted, we have visual-
ized cell junctions in the pancreas of newborn mice by
using electron microscopy and find adherens junctions
and desmosomes in conditional KO tissue, even be-
tween vacuolated cells (Figures 4I and 4J). Moreover,
E-cadherin is present at cell membranes of conditional
KO acini, confirming that adherens junctions are not
disrupted (Figures 4M and 4N). Plakoglobin/γ-catenin,
a component of desmosomes and adherens junctions,
may compensate for β-catenin loss in junctions [14, 27].
Plakoglobin is, however, present, but not upregulated,













iargely conserved in KO pancreas, but some acinar
ells appear fragmented, more round, and in the pro-
ess of exiting the epithelium (Figure 4L). These cells
ay allow the leakage of enzymes between acinar cells
nd therefore pancreatitis. The most affected cells are
n the process of dying, but we do not observe con-
ensed nuclei in conditional KO tissue, suggesting ab-
ence of apoptosis. In agreement with this observation,
leaved caspase 3, a marker of apoptosis, is found only
ccasionally in cells of conditional KOs and wt (data
ot shown). Cell proliferation in conditional KOs is de-
reased to 25% of control values as assessed by
mmunostaining for Ki67 (Figure 4K).
In addition to its expression in the pancreas, Pdx1
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1681is expressed in the duodenum during development, a
known site of Wnt pathway activity that we confirm in
the conductin reporter strain. Accordingly, we observe
fewer and shorter duodenal villi in conditional KOs (Fig-
ures 4E and 4F).
Adult Pancreas Totally Recovers
Despite pancreatitis and hypoproliferation at birth,
6-week-old conditional KO mice have a normal pan-
creas with no differences in size, cellular composition,
or architecture (Figure S3). β-catenin protein is present
at the plasma membrane of all exocrine cells. After
birth, the Pdx1 promoter is no longer active in exocrine
(acinar and ductal) cells. As many wt cells remain in the
newborn conditional KO pancreas, it is likely that these
cells replenish all exocrine tissue. In combination with
the absence of new recombination, this might lead to
recovery from pancreatitis. Regeneration is also ob-
served in the duodenum that exhibits normal villi in
6-week old mutants.
After birth, the Pdx1 promoter is active only in β cells
of the pancreas. Accordingly, β-catenin is largely absent
from adult islets (Figure S3), showing that β-catenin is
not required for maintenance and possible proliferation
of β cells. The proliferation index of islets (Ki67) in KO
and control animals is similar 4 days after birth. The
glycemic profile of 6 week conditional KO mice is nor-
mal during glucose tolerance tests (data not shown). In
addition, 14-month-old mice are normoglycemic.
Discussion
We analyze the activity of the Wnt/β-catenin pathway
and the role of β-catenin in pancreas development. By
using the conductin-lacZ and BAT-gal reporter strains,
we observe a restricted activity of this pathway in en-
docrine cells during development and at birth. Impor-
tantly, this activity in endocrine cells is corroborated by
the patterns of expression of Wnts and Frizzled. In-
deed, Wnt1 is expressed in the mesenchymal cells sur-
rounding the developing endocrine clusters at 15.5
dpc. Moreover, Frz2, Frz3, and Frz7 are expressed in
endocrine cells [6]. In agreement with Wnt pathway
activity in endocrine cells during development, our spe-
cific deletion of β-catenin in the pancreas results in re-
duced islet numbers. The Wnt pathway may be impor-
tant for the expansion or survival of endocrine cells
during development. In addition to its central role in the
Wnt signaling pathway, β-catenin binds to the cytoplas-
mic tail of E-cadherin in adherens junctions [28]. Our
experiments do not rule out that the loss of endocrine
cells may be due to the role of β-catenin at the mem-
brane. β-catenin loss may rapidly induce nonapoptotic
death of pancreatic or endocrine progenitors, leading
to a decrease of endocrine cell numbers. In adult mice,
we show that the Wnt pathway is not active in islets.
Moreover, our inactivation experiments show that β-cat-
enin is not necessary for function or homeostasis of β
cells or to maintain islet architecture. Indeed, glucose
tolerance is normal in these mice, and they display gly-
cemia similar to controls at the age of 14 months.
In the exocrine compartment, KO cells do not accu-
mulate over time. Even though recombination, as as-sessed with the R26R-YFP reporter, occurs in 57% of
cells in conditional KOs, we still detect β-catenin pro-
tein at 14.5 dpc around the membrane of 84% of epi-
thelial cells. The Pdx1 promoter is active as early as 8.5
dpc and persists throughout development in pancreas
progenitors. The number of cells recombined at the
R26R locus increase with time and double between
12.5 and 14.5 dpc. It is unlikely that stability of membra-
nous β-catenin solely accounts for this persistence.
One simple explanation is that recombination at the
β-catenin locus might be less efficient than at the R26R
locus. The accumulation of cells recombined at only
one locus is further documented in newborns where
90% of the epithelium is YFP+ but β-catenin levels are
normal by Western Blot. We know that the β-catenin
locus can be efficiently recombined in other tissues
[16–19], and in our experiments, β-catenin is largely ab-
sent from islets in adult mutants. Our observations sug-
gest that β-catenin KO cells cannot be maintained in
the exocrine compartment and are out competed by
wt cells. In favor of this model, less recombined cells
expressing YFP are observed in conditional KOs com-
pared to controls at 12.5 and 14.5 dpc (of importance,
the experimental setup provided the same number of
loxP sites) and the counter-selection increases be-
tween these two time points. β-catenin-deficient cells
are hypoproliferative. Continuous expression of Cre in
progenitors until birth should have nevertheless al-
lowed the progressive accumulation of KO cells dif-
ferentiating from progenitors. We therefore think that in
addition these cells die, possibly after exiting the epi-
thelium. Interestingly, these cells do not die by apopto-
sis, as the number of cells with cleaved caspase 3 or
apoptotic nuclei as detected by electron microscopy is
not increased. Compensatory expansion of wt cells
may explain why the size of the pancreas is otherwise
normal at 12.5 and 14.5 dpc. At 18.5 dpc, a slight hypo-
plasia, not observed from gross morphology, is de-
tected after quantification on sections.
At 18.5 dpc and in newborns, β-catenin inactivation
causes acute edematous pancreatitis, characterized by
infiltrated fluid, vacuolated tissue, and β-catenin dis-
placement from membranes. A strong increase in apo-
ptosis is not observed. Because none of the reporter
strains showed activity in acinar cells, it is likely that the
pancreatitis phenotype is independent of the canonical
Wnt pathway. By using electron microscopy and immu-
nofluorescence, we observe that adherens junctions
and desmosomes are present even between vacuo-
lated cells. In spite of its relocation, β-catenin is not
depleted in most exocrine cells and one may wonder
how pancreatitis is initiated. The presence of even few
KO cells may generate disorganized acini and lead to
the release of digestive enzymes between acini. Epithe-
lial disorganization is observed from 12.5 dpc (Figure
S1) and peaks perinatally when there are round cells
exiting the epithelium (Figure 4L). The phenotype ob-
served here is similar to that caused by cerulein, a cho-
lecystokinin analog that triggers massive enzymatic
release.
Our results using BAT-gal mice suggest canonical
Wnt pathway activity in mesenchymal cells in the pan-
creas. The Pdx1 promoter is not active in these cells.
The function of Wnts in the pancreas mesenchyme and
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be investigated. In the transgenic mice expressing
Wnt1 under the control of the Pdx1 promoter, hypopla-
sia was observed [6]. The opposite phenotype is not
observed here. In these experiments, Wnts may signal
to the mesenchyme, which then might influence the ep-
ithelium.
Activating mutations of β-catenin and loss-of-func-
tion mutations of APC were demonstrated in nonen-
docrine tumors of the pancreas: pancreatoblastomas
[1], acinar cell carcinomas [2], solid-cystic papillary tu-
mors, and solid pseudo papillary tumors [3, 4]. In the
intestinal epithelium, Wnt pathway activity is important
for development and homeostasis. In the duodenum
of newborn mutants, we observe loss of villi and de-
creased proliferation in agreement with previously
published experiments using overexpression of dick-
kopf-1, a Wnt pathway inhibitor, or β-catenin inactiva-
tion [29–31]. When Wnt signaling is overactivated by
mutations in APC, β-catenin or axin hyperproliferation
is induced, which eventually results in colon cancer. In
the pancreas, canonical Wnt pathway activity is not de-
tected in nonendocrine cells with both reporters we an-
alyzed. This suggests that the Wnt pathway is either
active at low levels or active in too few progenitor cells
to be detected during development and homeostasis.
Alternatively, a pathway that is not used in normal pan-
creas homeostasis might lead to tumor formation.
These activating mutations may alternatively impair the
function of β-catenin at the membrane and therefore
block contact-mediated arrest signaling [32]. The Wnt
pathway may also be relevant to endocrine tumors: in
the Men1 somatic-deleted mouse model, alteration of
E-cadherin and β-catenin expression is observed dur-
ing insulinoma progression [33] but no mutation of the
canonical Wnt pathway components were reported.
Experimental Procedures
Breeding Scheme and Genotyping
The breeding procedure is described in the Results. DNA isolated
from embryonic tissue or tail biopsies was used for genotyping
animals. PCR primers are described in the following references: for
Pdx1-Cre transgene [15], for b-cat+/lacZ [14], and floxed b-catenin [16].
Histology, Immunohistochemistry, BrdU Labeling,
and X-Gal Staining
Pancreas or whole digestive tracts were fixed in 4% paraformalde-
hyde for 30 min at room temperature and either dehydrated for
paraffin embedding or equilibrated in 15% phosphate-buffered su-
crose before embedding in gelatin. 7–10 m sections were col-
lected on SuperFrost Plus slides. For whole-mount immuno-
staining, digestive tracts were fixed in 4% formaldehyde for 30 min,
dehydrated in methanol, and stored at −20°C. Paraffin sections
were dewaxed, rehydrated to PBS, and stained with hematoxylin
and eosin (H&E) or Goldner trichrome using standard protocols. For
whole-mount immunostaining, tissues were rehydrated and incu-
bated in PGTA (0.2% gelatin, 1.6% blocking, 16% sheep serum,
0.25% Triton X-100, and 0.1% azide in PBS) with rabbit anti-Pdx1
antibody (a gift from Chris Wright) for 48 hr at 4°C.
For immunohistochemistry, we used the following primary anti-
bodies: rabbit anti-β-catenin ([14]; 1:400), mouse anti-E-cadherin
(BD Biosciences; 1:50), mouse anti-plakoglobin (BD Biosciences;
1:100), guinea pig anti-insulin (Dako; 1:100), rabbit anti-glucagon
(Zymed; 1:100), mouse anti-Ki67 (Novocastra Laboratories; 1:100),


























































Rnd rat anti-BrdU (Oxford Biotech; 1:200). Nuclei were counter-
tained with 4#,6-Diamidino-2-phenylindole (DAPI; Sigma).
For BrdU labeling of embryos, pregnant mice were injected intra-
eritoneally with 1 mg/20 g body weight of BrdU (Sigma) in PBS
–2 hr before sacrifice. lacZ expression was visualized in whole
igestive tracts or on sections by 5-bromo-4-chloro-3-indolyl β-D-
alactoside staining overnight at 37°C after fixation on ice for 30
in [34].
mmunoblot Analysis
roteins were extracted from the pancreas of newborn mice in a
uffer containing 9.5 M urea, 10 mM Tris-HCl (pH 8), 2 mM EDTA,
mM freshly added DTT, a cocktail of protease inhibitors (Com-
lete Mini, Roche), and 8 l aprotinin (Sigma) by homogenization
n ice. The insoluble part was removed by centrifugation. Protein
ontent was quantified according to Bradford by using a commer-
ially available solution (Biorad). 80 g samples and 10 g controls
ere fractionated by SDS-PAGE on a 8% gel. After transfer to a
itrocellulose membrane (Schleicher & Schuell, Protran BA85),
lots were incubated with a rabbit anti-β-catenin ([14]; 1:1000) or
ouse anti-γ-tubulin (Sigma, 1:2000) then with an anti-rabbit/
ouse IgG coupled to Horse Radish Peroxydase (Amersham,
:5000) for immunodetection by Enhanced Chemie Luminescence.
lectron Microscopy
ancreas from newborn mice were dissected and cut into small
locks, which were fixed for 2 hr at 4°C with 2.45% glutaraldehyde
n cacodylate buffer. Tissues were then postfixed with 1% osmium
etroxide in cacodylate buffer at room temperature for 1 hr, dehy-
rated, and immersed in propylen oxide. After incubation in a mix
f propylen oxide and EPON at room temperature, blocks were em-
edded in EPON and polymerized at 60°C. Sections were con-
rasted with uranylacetate and lead citrate.
lucose Tolerance Test
-week-old mice were starved overnight. 20 mg/10 g body weight
f a 20% glucose solution was injected intraperitoneally. Glucose
evel in blood was measured from tail by using a glucometer (Glu-
otrend, Roche) at time points 0 and then 30, 60, 90, and 120 min
fter injection.
upplemental Data
upplemental Data include three figures and are available with this
rticle online at http://www.current-biology.com/cig/content/full/
5/18/1677/DC1/.
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